India To Deliver HPV to Girls Aged 9 To 14 Soon: Dr NK Arora, NTAGI Chief

NTAGI chief Dr NK Arora said that India would soon be able to deliver HPV vaccination to girls aged nine to 14 as part of a nationwide programme.

Varun Verma
Written by: Varun VermaUpdated at: Dec 13, 2022 15:51 IST
India To Deliver HPV to Girls Aged 9 To 14 Soon: Dr NK Arora, NTAGI Chief

Dr NK Arora, the National Technical Advisory Group on Immunisation (NTAGI) chief, said that The HPV vaccination could cure cervical cancer. He added that India would soon be able to deliver HPV vaccination to girls aged nine to 14 as part of a nationwide programme. Earlier in August this year, the Serum Institute of India (SII), in collaboration with the Department of Biotechnology, announced to launch of India’s first vaccine against cervical cancer.

What Is HPV?

Human Papillomavirus (HPV) is a viral infection that spreads from person to person through skin-to-skin contact. Human Papillomavirus infection is one of the most prevailing sexually transmitted diseases (STDs), with over 100 types.

This viral infection is a sexually transmitted disease that can affect a person's genitals, throat, and mouth. Because each case is unique, HPV may not be an issue or cause any health concerns for many people, but it can cause genital warts and even cancer of the anus, cervix, and throat in other cases.

Also ReadIndia To Launch First qHPV Vaccine Against Cervical Cancer On September 1

What Is HPV Vaccine?

If administered before viral exposure, the HPV vaccination can help prevent the majority of cases of cervical cancer in girls and women. The HPV vaccination can protect against cancers such as the vulva or vaginal cancer. Furthermore, this vaccination may aid in the prevention of diseases like head and neck cancer, genital warts, and cancer of the anus.

While talking to ANI, Dr NK Arora, Chief of the National Technical Advisory Group on Immunisation (NTAGI), said that The HPV vaccination could cure cervical cancer. He added that India would soon be able to deliver HPV vaccination to girls aged nine to 14 as part of a nationwide programme.

On the HPV vaccine, Dr NK Arora said that screening for cervical illness beyond the age of 35 is critical and early detection is controllable at the primary health centre (PHC). He emphasised that screening must be viewed as a mission. Cervical cancer is the leading cause of mortality in India, with about 80,000 cases diagnosed yearly.

Also ReadHPV Vaccine: Who Needs It And How Does It Work? Clarifies Expert

Earlier in August this year, the Serum Institute of India (SII), in collaboration with the Department of Biotechnology, announced to launch of India’s first vaccine against cervical cancer. 

According to the World Health Organization (WHO), India accounts for almost one-fifth of the overall global burden of cervical cancer, with approximately 1.23 lakh cases and 67,000 deaths annually. The data analysis revealed that the new vaccination could aid in the prevention of HPV types 6, 11, 16, and 18. According to the DBT, the indigenous vaccine is cost-effective and cheap.

Image Credits: freepik

Disclaimer